Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "Molybdenum cofactor deficiency"
Show Display Options
RSS Create an RSS feed from your search for:
"Molybdenum cofactor deficiency"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
Condition: Molybdenum Cofactor Deficiency
Intervention:
2 Recruiting Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type A
Condition: Molybdenum Cofactor Deficiency, Type A
Intervention: Drug: ALXN1101
3 Withdrawn Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A
Condition: Molybdenum Cofactor Deficiency Type A
Intervention: Drug: cPMP
4 Active, not recruiting Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Condition: Molybdenum Cofactor Deficiency, Type A
Intervention: Drug: ALXN1101
5 Completed A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies
Conditions: Molybdenum Cofactor Deficiency;   Isolated Sulfite Oxidase Deficiency
Intervention:
6 Completed Phase 1 Single Dose Study of ALXN1101 in Healthy Volunteers
Conditions: Molybdenum Cofactor Deficiency (MoCD);   Rare Autosomal Recessive Disorder;   Deficiency of Activity of Molybdenum-dependent Enzymes (Sulfite Oxidase [SOX], Xanthine Dehydrogenase, and Aldehyde Oxidase)
Interventions: Drug: ALXN1101;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.